Sage Journals: Discover world-class research

Open access

Case report

First published 2021

Tumor lysis Syndrome in a Patient with Metastatic Breast Cancer Treated with Alpelisib

Caitlin Handy, Robert Wesolowski, Michelle Gillespie [...]

Breast Cancer: Basic and Clinical Research

Retricted access

Research article

First published 2022-7

The efficacy and safety of alpelisib in breast cancer: A real-world analysis

Jenn Miller, Emily Armgardt, Alison Svoboda

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-3

Alpelisib induced interstitial lung disease in a patient with advanced breast cancer

Aysun Isiklar, Gul Basaran, Beyza Sepin [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2023-4

BYL719 (alpelisib) for the treatment of PIK3CA-mutated,recurrent/advanced cervical cancer

Giorgio Bogani, Valentina Chiappa, Marta Bini [...]

Tumori Journal

Open access

Case report

First published 2021

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series

Tahj Blow, Parker N. Hyde, John N. Falcone [...]

Integrative Cancer Therapies

Open access

Case report

First published 2022

S.U.G.A.R: A Case to Outline Tactics for the Prevention of Alpelisib-Induced Hyperglycemia

Katharine Thomas, Monique Germain, Michelle M. Loch

Journal of Investigative Medicine High Impact Case Reports

Open access

Case report

First published 2024

Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety

Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro

Emil Chteinberg, Suzan Wetzels, Wouter Gerritsen [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia

Marcus D. Goncalves, Azeez Farooki

Integrative Cancer Therapies

Retricted access

Research article

First published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Search results